Tapewire

Nasdaq · USD

ACRV

Acrivon Therapeutics, Inc.

Export transactions ↓
Tapewire entity
573
SEC CIK
0001781174
Parsed reports
205

Last 12 months

Inside the activity.

3 purchase rows · 10 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202630
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202601
Aug 202608
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 17, 2025 Filed Apr 18, 2025 19:51 UTC
Miller MaryChief Legal Officer
Tax withholdingCommon Stock 558 $1.81 $1,009.98
Disclosure

SEC source: 0000905148-25-001257 · form4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,507

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:32 UTC
Miller MaryChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 15,616 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0000905148-25-001076 · form4.xml · derivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,616

Underlying: Common Stock · 15,616 shares

Expires 2035-03-31

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on April 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 20:30 UTC
Levy Adam D.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 35,209 $0.00 Strike: $1.68 $0.00
Disclosure

SEC source: 0000905148-25-001075 · form4.xml · derivative · entry 1

Levy Adam D. · CIK 0002061876 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,209

Underlying: Common Stock · 35,209 shares

Expires 2035-03-31

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on April 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 22:36 UTC
Peterson KatharineChief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 31,900 $0.00 Strike: $5.31 $0.00
Disclosure

SEC source: 0000905148-25-000842 · form4.xml · derivative · entry 1

Peterson Katharine · CIK 0002022214 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,900

Underlying: Common Stock · 31,900 shares

Expires 2035-02-28

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 17:13 UTC
Cuillerot Jean-MarieChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 78,078 $0.00 Strike: $5.31 $0.00
Disclosure

SEC source: 0000905148-25-000831 · form4.xml · derivative · entry 1

Cuillerot Jean-Marie · CIK 0001696108 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,078

Underlying: Common Stock · 78,078 shares

Expires 2035-02-28

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 22:31 UTC
Miller MaryChief Legal Officer
GrantStock Option (Right to Buy) · Derivative 93,693 $0.00 Strike: $5.31 $0.00
Disclosure

SEC source: 0000905148-25-000840 · form4.xml · derivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,693

Underlying: Common Stock · 93,693 shares

Expires 2035-02-28

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 22:28 UTC
Holm-Jorgensen RasmusChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 109,309 $0.00 Strike: $5.31 $0.00
Disclosure

SEC source: 0000905148-25-000838 · form4.xml · derivative · entry 1

Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,309

Underlying: Common Stock · 109,309 shares

Expires 2035-02-28

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 22:24 UTC
Gamelin ErickChief Development Officer
GrantStock Option (Right to Buy) · Derivative 78,078 $0.00 Strike: $5.31 $0.00
Disclosure

SEC source: 0000905148-25-000836 · form4.xml · derivative · entry 1

Gamelin Erick · CIK 0001950551 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,078

Underlying: Common Stock · 78,078 shares

Expires 2035-02-28

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 22:21 UTC
Devroe EricChief Operating Officer
GrantStock Option (Right to Buy) · Derivative 140,540 $0.00 Strike: $5.31 $0.00
Disclosure

SEC source: 0000905148-25-000834 · form4.xml · derivative · entry 1

Devroe Eric · CIK 0001950573 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,540

Underlying: Common Stock · 140,540 shares

Expires 2035-02-28

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 22:11 UTC
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
GrantStock Option (Right to Buy) · Derivative 140,540 $0.00 Strike: $5.31 $0.00
Disclosure

SEC source: 0000905148-25-000828 · form4.xml · derivative · entry 2

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 140,540

Underlying: Common Stock · 140,540 shares

Expires 2035-02-28

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

F3 · ownership.nature: These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Read SEC document
March 01, 2025 Filed Mar 4, 2025 22:11 UTC
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
GrantStock Option (Right to Buy) · Derivative 390,390 $0.00 Strike: $5.31 $0.00
Disclosure

SEC source: 0000905148-25-000828 · form4.xml · derivative · entry 1

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 390,390

Underlying: Common Stock · 390,390 shares

Expires 2035-02-28

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.

F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.

Read SEC document
February 21, 2025 Filed Feb 25, 2025 21:09 UTC
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
Tax withholdingCommon Stock 19,904 $5.54 $110,268.16
Disclosure

SEC source: 0000905148-25-000764 · form4.xml · nonDerivative · entry 1

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,285,781

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 22:00 UTC
Peterson KatharineChief Accounting Officer
Tax withholdingCommon Stock 116 $5.42 $628.72
Disclosure

SEC source: 0000905148-25-000730 · form4.xml · nonDerivative · entry 1

Peterson Katharine · CIK 0002022214 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,419

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:59 UTC
Miller MaryChief Legal Officer
Tax withholdingCommon Stock 217 $5.42 $1,176.14
Disclosure

SEC source: 0000905148-25-000729 · form4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,065

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:55 UTC
Holm-Jorgensen RasmusChief Financial Officer
Tax withholdingCommon Stock 434 $5.42 $2,352.28
Disclosure

SEC source: 0000905148-25-000728 · form4.xml · nonDerivative · entry 1

Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,088

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:54 UTC
Gamelin ErickChief Development Officer
Tax withholdingCommon Stock 469 $5.42 $2,541.98
Disclosure

SEC source: 0000905148-25-000727 · form4.xml · nonDerivative · entry 1

Gamelin Erick · CIK 0001950551 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,492

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:53 UTC
Devroe EricChief Operating Officer
Tax withholdingCommon Stock 724 $5.42 $3,924.08
Disclosure

SEC source: 0000905148-25-000726 · form4.xml · nonDerivative · entry 1

Devroe Eric · CIK 0001950573 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,147

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:52 UTC
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
Tax withholdingCommon Stock 579 $5.42 $3,138.18
Disclosure

SEC source: 0000905148-25-000725 · form4.xml · nonDerivative · entry 2

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 316,177

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

F3 · ownership.nature: These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Read SEC document
February 14, 2025 Filed Feb 19, 2025 21:52 UTC
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
Tax withholdingCommon Stock 37,152 $5.42 $201,363.84
Disclosure

SEC source: 0000905148-25-000725 · form4.xml · nonDerivative · entry 1

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,305,685

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.

Read SEC document
January 17, 2025 Filed Jan 22, 2025 21:15 UTC
Miller MaryChief Legal Officer
Tax withholdingCommon Stock 659 $5.78 $3,809.02
Disclosure

SEC source: 0000905148-25-000168 · form4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,282

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
November 21, 2024 Filed Nov 25, 2024 21:29 UTC
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
Tax withholdingCommon Stock 19,910 $6.44 $128,220.40
Disclosure

SEC source: 0000905148-24-003270 · form4.xml · nonDerivative · entry 1

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,342,837

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:32 UTC
Peterson KatharineChief Accounting Officer
Tax withholdingCommon Stock 99 $7.92 $784.08
Disclosure

SEC source: 0000905148-24-003228 · form4.xml · nonDerivative · entry 1

Peterson Katharine · CIK 0002022214 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,535

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:31 UTC
Miller MaryChief Legal Officer
Tax withholdingCommon Stock 184 $7.92 $1,457.28
Disclosure

SEC source: 0000905148-24-003227 · form4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,941

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:30 UTC
Holm-Jorgensen RasmusChief Financial Officer
Tax withholdingCommon Stock 368 $7.92 $2,914.56
Disclosure

SEC source: 0000905148-24-003226 · form4.xml · nonDerivative · entry 1

Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,522

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:29 UTC
Gamelin ErickChief Development Officer
Tax withholdingCommon Stock 402 $7.92 $3,183.84
Disclosure

SEC source: 0000905148-24-003225 · form4.xml · nonDerivative · entry 1

Gamelin Erick · CIK 0001950551 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,961

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:28 UTC
Devroe EricChief Operating Officer
Tax withholdingCommon Stock 613 $7.92 $4,854.96
Disclosure

SEC source: 0000905148-24-003224 · form4.xml · nonDerivative · entry 1

Devroe Eric · CIK 0001950573 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,871

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:26 UTC
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
Tax withholdingCommon Stock 490 $7.92 $3,880.80
Disclosure

SEC source: 0000905148-24-003223 · form4.xml · nonDerivative · entry 2

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 316,756

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

F3 · ownership.nature: These securities are held by co-founder and EVP, Dr. Kristina Masson, who is also Dr. Blume-Jensen's spouse. Dr. Blume-Jensen disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.

Read SEC document
November 14, 2024 Filed Nov 18, 2024 21:26 UTC
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
Tax withholdingCommon Stock 59,766 $7.92 $473,346.72
Disclosure

SEC source: 0000905148-24-003223 · form4.xml · nonDerivative · entry 1

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,362,747

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.

Read SEC document
October 17, 2024 Filed Oct 21, 2024 20:22 UTC
Miller MaryChief Legal Officer
Tax withholdingCommon Stock 558 $7.87 $4,391.46
Disclosure

SEC source: 0000905148-24-002773 · form4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,125

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
October 01, 2024 Filed Oct 3, 2024 22:49 UTC
Miller MaryChief Legal Officer
Tax withholdingCommon Stock 284 $6.98 $1,982.32
Disclosure

SEC source: 0000905148-24-002637 · form4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,683

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
August 21, 2024 Filed Aug 23, 2024 20:11 UTC
Blume-Jensen PeterDirector · President and CEO
Masson KristinaDirector · EVP - Business Operations
Tax withholdingCommon Stock 79,616 $9.19 $731,671.04
Disclosure

SEC source: 0000905148-24-002335 · form4.xml · nonDerivative · entry 1

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,422,513

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

F2 · ownership.direct: These securities are held by President and CEO, Dr. Peter Blume-Jensen, who is also Dr. Kristina Masson's spouse. Dr. Masson disclaims beneficial ownership of such securities except to the extent of her pecuniary interest therein.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:53 UTC
Peterson KatharineChief Accounting Officer
Tax withholdingCommon Stock 99 $7.02 $694.98
Disclosure

SEC source: 0000905148-24-002283 · form4.xml · nonDerivative · entry 1

Peterson Katharine · CIK 0002022214 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,634

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:52 UTC
Miller MaryChief Legal Officer
Tax withholdingCommon Stock 184 $7.02 $1,291.68
Disclosure

SEC source: 0000905148-24-002282 · form4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,967

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:52 UTC
Masson KristinaDirector · EVP - Business Operations
Tax withholdingCommon Stock 490 $7.02 $3,439.80
Disclosure

SEC source: 0000905148-24-002281 · form4.xml · nonDerivative · entry 1

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,246

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:51 UTC
Holm-Jorgensen RasmusChief Financial Officer
Tax withholdingCommon Stock 368 $7.02 $2,583.36
Disclosure

SEC source: 0000905148-24-002280 · form4.xml · nonDerivative · entry 1

Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,890

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:50 UTC
Gamelin ErickChief Development Officer
Tax withholdingCommon Stock 402 $7.02 $2,822.04
Disclosure

SEC source: 0000905148-24-002279 · form4.xml · nonDerivative · entry 1

Gamelin Erick · CIK 0001950551 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,363

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:48 UTC
Devroe EricChief Operating Officer
Tax withholdingCommon Stock 613 $7.02 $4,303.26
Disclosure

SEC source: 0000905148-24-002278 · form4.xml · nonDerivative · entry 1

Devroe Eric · CIK 0001950573 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,484

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
August 14, 2024 Filed Aug 16, 2024 20:47 UTC
Blume-Jensen PeterDirector · President and CEO
Tax withholdingCommon Stock 59,765 $7.02 $419,550.30
Disclosure

SEC source: 0000905148-24-002277 · form4.xml · nonDerivative · entry 1

Blume-Jensen Peter · CIK 0001950499 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,502,129

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
July 17, 2024 Filed Jul 19, 2024 20:20 UTC
Miller MaryChief Legal Officer
Tax withholdingCommon Stock 558 $7.69 $4,291.02
Disclosure

SEC source: 0001140361-24-033600 · form4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,151

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 21:36 UTC
RA CAPITAL MANAGEMENT, L.P.Director · 10% owner
RA Capital Healthcare Fund LPDirector · 10% owner
Kolchinsky PeterDirector · 10% owner
Shah Rajeev M.Director · 10% owner
GrantStock Option (Right to Buy) · Derivative 20,275 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0001415889-24-018035 · form4-06242024_090612.xml · derivative · entry 1

RA CAPITAL MANAGEMENT, L.P. · CIK 0001346824 · Director · 10% owner

RA Capital Healthcare Fund LP · CIK 0001315082 · Director · 10% owner

RA Capital Nexus Fund II, L.P. · CIK 0001825376 · Director

Kolchinsky Peter · CIK 0001384859 · Director · 10% owner

Shah Rajeev M. · CIK 0001619841 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnotes

Disclosed balance after: 20,275

Underlying: Common Stock · 20,275 shares

Expires 2034-06-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to Dr. Derek DiRocco's continuous service through each applicable vesting date.

F2 · ownership.nature: RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. Each of the Adviser, the Adviser GP, the Fund, the Nexus Fund II, Dr. Kolchinsky and Mr. Shah disclaims beneficial ownership of any of the reported securities, except to the extent of its or his respective pecuniary interest therein.

F3 · ownership.nature: Derek DiRocco is a Partner of the Adviser who serves on the Issuer's board of directors. Under Dr. DiRocco's arrangement with the Adviser, Dr. DiRocco holds the option for the benefit of the Fund and the Nexus Fund II. Dr. DiRocco is obligated to turn over to the Adviser any net cash or stock received upon exercise of the option, which will offset advisory fees owed by the Fund and the Nexus Fund II to the Adviser. The Reporting Persons therefore disclaim beneficial ownership of the option and underlying common stock.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 21:28 UTC GrantStock Option (Right to Buy) · Derivative 20,275 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0000905148-24-001777 · form4.xml · derivative · entry 1

TOMSICEK MICHAEL JOHN · CIK 0001570392 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,275

Underlying: Common Stock · 20,275 shares

Expires 2034-06-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 21:26 UTC GrantStock Option (Right to Buy) · Derivative 20,275 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0000905148-24-001774 · form4.xml · derivative · entry 1

BAUM CHARLES M · CIK 0001579824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,275

Underlying: Common Stock · 20,275 shares

Expires 2034-06-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 21:27 UTC GrantStock Option (Right to Buy) · Derivative 20,275 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0000905148-24-001776 · form4.xml · derivative · entry 1

Shacham Sharon · CIK 0001588438 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,275

Underlying: Common Stock · 20,275 shares

Expires 2034-06-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 21:27 UTC GrantStock Option (Right to Buy) · Derivative 20,275 $0.00 Strike: $6.52 $0.00
Disclosure

SEC source: 0000905148-24-001775 · form4.xml · derivative · entry 1

DiRocco Derek · CIK 0001792061 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,275

Underlying: Common Stock · 20,275 shares

Expires 2034-06-19

F1 · derivative.exercise_date: The shares subject to the option shall vest on the date immediately preceding the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service through each applicable vesting date.

F2 · ownership.direct: Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the stock option for the benefit of RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus Fund II, L.P. (the "Nexus Fund II"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received upon exercise of the stock option, which will offset advisory fees owed by the Fund and the Nexus Fund II. The Reporting Person therefore disclaims beneficial ownership of the stock option and underlying Common Stock.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:04 UTC
Devroe EricChief Operating Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $1.04 $0.00
Disclosure

SEC source: 0000905148-24-001566 · form4.xml · derivative · entry 2

Devroe Eric · CIK 0001950573 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,615

Underlying: Common Stock · 10,000 shares

Expires 2031-01-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares subject to the option vested on October 5, 2021, and the remaining shares subject to the option vested or shall vest in 12 equal quarterly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date.

Read SEC document
May 17, 2024 Filed May 21, 2024 20:04 UTC
Devroe EricChief Operating Officer
Exercise / conversionCommon Stock 10,000 $1.04 $10,400.00
Disclosure

SEC source: 0000905148-24-001566 · form4.xml · nonDerivative · entry 1

Devroe Eric · CIK 0001950573 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,097

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 14, 2024 Filed May 16, 2024 23:05 UTC
Peterson KatharineChief Accounting Officer
Tax withholdingCommon Stock 99 $8.36 $827.64
Disclosure

SEC source: 0000905148-24-001495 · form4.xml · nonDerivative · entry 1

Peterson Katharine · CIK 0002022214 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,733

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
May 14, 2024 Filed May 16, 2024 23:03 UTC
Miller MaryChief Legal Officer
Tax withholdingCommon Stock 184 $8.36 $1,538.24
Disclosure

SEC source: 0000905148-24-001493 · form4.xml · nonDerivative · entry 1

Miller Mary · CIK 0001841088 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,709

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
May 14, 2024 Filed May 16, 2024 23:02 UTC
Masson KristinaDirector · EVP - Business Operations
Tax withholdingCommon Stock 490 $8.36 $4,096.40
Disclosure

SEC source: 0000905148-24-001491 · form4.xml · nonDerivative · entry 1

Masson Kristina · CIK 0001950501 · Director · EVP - Business Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 317,736

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document
May 14, 2024 Filed May 16, 2024 23:00 UTC
Holm-Jorgensen RasmusChief Financial Officer
Tax withholdingCommon Stock 368 $8.36 $3,076.48
Disclosure

SEC source: 0000905148-24-001489 · form4.xml · nonDerivative · entry 1

Holm-Jorgensen Rasmus · CIK 0001950496 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,258

F1 · kind: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.